HARBIN, China--(BUSINESS WIRE)--Renhuang Pharmaceuticals, Inc. (or “the Company”, Stock symbol: RHGP.OB), a leading integrated developer, manufacturer and distributor of a broad line of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products in the People’s Republic of China (PRC), today announced that its Board of Directors has appointed Magnus Moliteus, former Chief Executive Officer and President of Pharmacia Inc. and a seasoned executive in the healthcare industry, as an independent director, effective April 16, 2007.
